Fig. 2From: A novel biomarker of chronic allograft dysfunction in renal transplant recipients (serum calreticulin and CD47)Serum calreticulin (CRT) (ng/ml) in renal transplant recipients with stable allograft function (group I), chronic allograft dysfunction (group II), and in control subjects (group III)Back to article page